Full Breakdown
South Korea Moves Toward First Official Authorization of Abortion Pills
By Drooid · · How we work
Government Plan and Timeline
The South Korean government announced that it intends to permit medication abortions for pregnancies up to nine weeks, with the first approvals expected in the early part of 2027. For the initial two-year period, doctors will both prescribe and dispense the two-drug combination of mifepristone and misoprostol. After this phase, the system will shift so that doctors issue prescriptions while pharmacies handle dispensing. The plan includes approving a local company’s application to import the drug pack, which is already widely used in the United States and elsewhere.
Legal and Historical Context
The initiative follows a 2019 ruling by the Constitutional Court that ordered the relaxation of a decades-old ban on most abortions. Although the court’s decision decriminalized abortion, parliament has not yet revised related statutes, leaving a regulatory gap that forces some women to obtain abortion drugs through unverified online sources. As of 2024, roughly one hundred countries had permitted abortion pills, highlighting South Korea’s lag in formalizing access.
Official Government Rationale
Gender Equality and Family Minister Won Min-kyong framed the move as a step toward safer terminations within the national health system. Prime Minister Han Seong Sook warned that women are resorting to dangerous methods and stressed that safety must take precedence, arguing that the policy seeks to protect public health rather than promote abortion. President Lee Jae Myung, who directed officials in July to explore the two-drug combination, has positioned the effort as part of a broader analysis to ensure safe, regulated access.
Opposition and Concerns
The Catholic Bishops’ Conference of Korea expressed deep concerns, characterizing the proposal as a disregard for human life. The Korean Association of Obstetricians & Gynecologists highlighted unresolved safety issues, such as incomplete miscarriage and heavy bleeding, and called for legislation that provides legal protection for physicians prescribing the pills for social or economic reasons. Conversely, the Korea Women’s Associations United welcomed the announcement, urging that the pills be made readily accessible and covered by national health insurance.
Next Steps
Final approval of the medication-abortion plan remains pending. If authorized, the government will move forward with importing the drug combination and establishing the phased dispensing model, while continuing discussions on insurance coverage and additional legal safeguards.